These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11291163)

  • 21. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular health: the emerging appreciation of the endothelium.
    Talley JD
    J Ark Med Soc; 1997 Feb; 93(9):454-5. PubMed ID: 9046759
    [No Abstract]   [Full Text] [Related]  

  • 23. Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
    Mancini GB
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):293-5. PubMed ID: 11800410
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.
    Schneider CA; Voth E; Moka D; Baer FM; Melin J; Bol A; Wagner R; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1999 Oct; 34(4):1005-11. PubMed ID: 10520782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study].
    Eleuteri E
    Ital Heart J Suppl; 2000 Jun; 1(6):830-1. PubMed ID: 11204017
    [No Abstract]   [Full Text] [Related]  

  • 26. Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction.
    Anderson T
    Can J Cardiol; 1998 Jul; 14 Suppl D():33D-34D. PubMed ID: 9713430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical data: AVERT and QUO VADIS.
    O'Neill BJ
    Can J Cardiol; 2000 Aug; 16 Suppl E():32E-35E. PubMed ID: 10906624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
    van Geel PP; Buikema H; Rouleau JL; van Gilst WH
    Can J Cardiol; 2003 May; 19(6):701-4. PubMed ID: 12774785
    [No Abstract]   [Full Text] [Related]  

  • 29. [Coronary heart disease patient with no ischemic symptoms. Does he still profit from an ACE inhibitor?].
    MMW Fortschr Med; 2003 Sep; 145(38):12. PubMed ID: 14603673
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular protection and repair and angiotensin converting enzyme (ACE) inhibitors.
    Birbari AE
    J Med Liban; 1995; 43(4):182. PubMed ID: 8885549
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease.
    Mancini GB
    Am J Med; 1998 Jul; 105(1A):40S-47S. PubMed ID: 9707267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF; Bareford D; Beevers DG
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular profile of the ACE-inhibitor Quinapril. Worshop report. Freiburg in Breisgau, 15-16 May 1992].
    Fortschr Med Monogr; 1992; 60():1-23. PubMed ID: 1366232
    [No Abstract]   [Full Text] [Related]  

  • 36. Quinapril ischemic event trial.
    Mancini GB
    Am J Cardiol; 2001 Dec; 88(11):1348. PubMed ID: 11728375
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ACE inhibitor to coronary patients: ramipril reduces mortality according to HOPE trial.
    Prescrire Int; 2001 Apr; 10(52):62-3. PubMed ID: 11718163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibitors for hypertension--again.
    Black P; Wrapson C
    N Z Med J; 2001 Apr; 114(1130):194. PubMed ID: 11396672
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition.
    Longobardi G; Ferrara N; Furgi G; Abete P; Rengo F
    J Am Coll Cardiol; 2000 Oct; 36(4):1437-8. PubMed ID: 11028513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.